TipRanks
Advertisement
Advertisement

LCTX Stock Latest News

Lineage Cell announces issuance of patent underlying AlloSCOPE 5D platform
The FlyLineage Cell announces issuance of patent underlying AlloSCOPE 5D platform
8d ago
LCTX
Lineage Cell Therapeutics management to meet with B. Riley
PremiumThe Fly
Lineage Cell Therapeutics management to meet with B. Riley
23d ago
LCTX
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
PremiumRatings
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
1M ago
LCTX
Lineage Cell Therapeutics Balances Progress and Risk
PremiumCompany Announcements
Lineage Cell Therapeutics Balances Progress and Risk
1M ago
LCTX
Lineage Maintained at Buy as Analyst Cites Clinical Momentum and Strategic Backing; $9 Price Target Reaffirmed
PremiumRatings
Lineage Maintained at Buy as Analyst Cites Clinical Momentum and Strategic Backing; $9 Price Target Reaffirmed
1M ago
LCTX
Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
PremiumThe FlyLineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
1M ago
LCTX
LCTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LCTX Upcoming Earnings Report: What to Expect?
1M ago
LCTX
Lineage Cell Therapeutics provides update on COR1 program
Premium
The Fly
Lineage Cell Therapeutics provides update on COR1 program
2M ago
LCTX
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
PremiumCompany Announcements
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
3M ago
8K
LCTX
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
PremiumCompany Announcements
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
4M ago
LCTX
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
4M ago
LCTX
Lineage Cell sees cash, equivalents funding operations into 2Q28
PremiumThe Fly
Lineage Cell sees cash, equivalents funding operations into 2Q28
4M ago
LCTX
Options Volatility and Implied Earnings Moves Today, May 12, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, May 12, 2026
4M ago
LAR
OGI
LCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LCTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
LCTX
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
Premium
The Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
5M ago
CHRO
LCTX
Lineage Cell Therapeutics initiated with a Buy at Canaccord
PremiumThe Fly
Lineage Cell Therapeutics initiated with a Buy at Canaccord
5M ago
LCTX
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
PremiumThe Fly
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
5M ago
LCTX
Lineage Cell Therapeutics management to meet with Craig-Hallum
PremiumThe Fly
Lineage Cell Therapeutics management to meet with Craig-Hallum
5M ago
LCTX
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
PremiumThe Fly
Lineage Cell Therapeutics price target raised to $4 from $3 at B. Riley
6M ago
LCTX
Lineage Cell launches cell therapy program in corneal endothelial disease
PremiumThe FlyLineage Cell launches cell therapy program in corneal endothelial disease
6M ago
LCTX
Lineage Therap Expands ATM Equity Offering Capacity
Premium
Company Announcements
Lineage Therap Expands ATM Equity Offering Capacity
6M ago
8K
LCTX
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
Premium
Company Announcements
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
6M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >